Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components

OBJECTIVES—To investigate the potential clinical benefit of a combination therapy.
METHODS—205 patients fulfilling the ACR criteria for rheumatoid arthritis (RA), not treated with disease modifying anti-rheumatoid drugs previously, with an early (⩽1 year duration), active (Disease Activity Score (DA...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dougados, M., Combe, B., Cantagrel, A., Goupille, P., Olive, P., Schattenkirchner, M., Meusser, S, Paimela, L, Rau, R., Zeidler, H., Leirisalo-Repo, M., Peldan, K.
Médium: Artigo
Jazyk:Inglês
Vydáno: 1999
Témata:
Extended Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1752864/
https://ncbi.nlm.nih.gov/pubmed/10364900
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky